我是 LongbridgeAI，我可以总结文章信息。吉利德科学已将其对 Arcellx 股票的收购要约截止日期延长至 4 月 24 日下午 5 点（东部时间），之前的截止日期为 4 月 3 日。截至 3 月 31 日，仅约 7.5% 的股票已被提交。该笔 78 亿美元的交易已获得两家公司董事会的批准，预计将在第二季度完成，吉利德将以每股 115 美元的现金和每股 5 美元的附带价值权进行收购
Gilead Sciences (GILD) has extended the expiration date of its tender offer for all common shares of Arcellx (ACLX) to 5p ET on April 24. It was midnight on April 3 prior. The biotech giant noted that as of 5p ET on March 31, only ~7.5% of outstanding shares have been tendered. The deal, worth up to $7.8B, has already been approved by both compani...